SCHEMBL3093582

SCHEMBL3093582

CCCC(CC)C(C)CO

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.52
TSHR P16473 3/20 0.48
ALDH1A1 P00352 1/20 0.37
METAP1 P53582 2/20 0.33
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1614480 0.86 TSHR (0.50) LMNATSHRALDH1A1METAP1TDP1
SCHEMBL3097828 0.85 ALDH1A1 (0.50) LMNATSHRALDH1A1TDP1
SCHEMBL1168877 0.84 LMNA (0.41) LMNATSHRALDH1A1TDP1
SCHEMBL7145506 0.83 LMNA (0.64) LMNATSHRALDH1A1METAP1TDP1
SCHEMBL1027870 0.83
SCHEMBL27938971 0.81 LMNA (0.52) LMNATSHRALDH1A1
SCHEMBL3028361 0.80 LMNA (0.40) LMNATSHRMETAP1
SCHEMBL1613788 0.80
SCHEMBL598055 0.80 LMNA (0.40) LMNATSHRMETAP1
SCHEMBL11589327 0.80 TSHR (0.50) LMNATSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9688838-B1 Diisononyl terephthalate plasticizer and its use as well as process for producing the same NAN YA PLASTICS CORPORATION (TW) 2017-06-27 US claimed
US-12624164-B2 Synthetic thickeners incorporating non-reactive diluents HERCULES LLC (US) 2026-05-12 US disclosed
US-12590181-B2 Hydrophobically-modified associative thickener polymers process for the preparation and uses thereof HERCULES LLC (US) 2026-03-31 US disclosed
EP-4192923-B1 HYDROPHOBICALLY-MODIFIED ASSOCIATIVE THICKENER POLYMERS PROCESS FOR THE PREPARATION AND USES THEREOF HERCULES LLC (US) 2025-10-29 EP disclosed
CN-116324124-B Hydrophobically modified associative thickener polymer and preparation method and application thereof 赫尔克里士有限公司 2025-03-18 CN disclosed
CN-116324123-B Hydrophobically modified associative thickener polymer and preparation method and application thereof 赫尔克里士有限公司 2025-03-18 CN disclosed
US-20230323138-A1 HYDROPHOBICALLY-MODIFIED ASSOCIATIVE THICKENER POLYMERS PROCESS FOR THE PREPARATION AND USES THEREOF HERCULES LLC (US) 2023-10-12 US disclosed
US-20230257522-A1 HYDROPHOBICALLY-MODIFIED ASSOCIATIVE THICKENER POLYMERS PROCESS FOR THE PREPARATION AND USES THEREOF HERCULES LLC (US) 2023-08-17 US disclosed
CN-116324124-A Hydrophobically modified associative thickener polymer and preparation method and application thereof 赫尔克里士有限公司 2023-06-23 CN disclosed
CN-116324123-A Hydrophobically modified associative thickener polymer and preparation method and application thereof 赫尔克里士有限公司 2023-06-23 CN disclosed
EP-0460950-B1 Radicicol derivatives, their preparation and their anti-tumour activity SANKYO CO (JP) 1997-03-05 EP disclosed
US-5597846-A ESTERS OF RADICICOL SANKYO COMPANY, LIMITED (JP) 1997-01-28 US disclosed
US-5559109-A Method of treating a PAF-mediated pathology or for treating or preventing psoriasis, nephritis, asthma or shock by administering a PAF antagonist SANKKO COMPANY, LIMITED (JP) 1996-09-24 US disclosed
US-5556852-A PLATELET ACTIVATING FACTOR ANTAGONISTS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
EP-0395446-B1 N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists SANKYO CO (JP) 1995-03-01 EP disclosed
US-5369106-A N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists SANKYO COMPANY, LIMITED (JP) 1994-11-29 US disclosed
US-5192766-A Platelet activating factor antagonist SANKYO COMPANY, LIMITED (JP) 1993-03-09 US disclosed
WO-1991018905-A1 RADICICOL DERIVATIVES, THEIR PREPARATION AND THEIR ANTI-TUMOR ACTIVITY SANKYO COMPANY LIMITED (JP) 1991-12-12 WO disclosed
EP-0460950-A1 Radicicol derivatives, their preparation and their anti-tumour activity Sankyo Company Limited (JP) 1991-12-11 EP disclosed
EP-0395446-A2 N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists Sankyo Company Limited (JP) 1990-10-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624164-B2 Synthetic thickeners incorporating non-reactive diluents GEMIN4, MAGT1, SETDB1 LMNA 3700/4885TSHR 3556/4885ALDH1A1 2580/4885
US-12590181-B2 Hydrophobically-modified associative thickener polymers process for the preparation and uses thereof PHOSPHO1, H1-10, H1-0 LMNA 2634/4885TSHR 3461/4885ALDH1A1 4014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.